APA (7th ed.) Citation

Ó, M., A, T., N, L., E, S., R, S., V, A., . . . J, S. (2026). Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study. Cardiovascular diabetology, 25(1), . https://doi.org/10.1186/s12933-026-03156-6

Chicago Style (17th ed.) Citation

Ó, Moreno-Pérez, et al. "Inpatient Safety, Effectiveness of SGLT2 Inhibitors and GLP-1 RAs in Type 2 Diabetes: ENDOCARE, a Pragmatic Prospective Cohort Study." Cardiovascular Diabetology 25, no. 1 (2026). https://doi.org/10.1186/s12933-026-03156-6.

MLA (9th ed.) Citation

Ó, Moreno-Pérez, et al. "Inpatient Safety, Effectiveness of SGLT2 Inhibitors and GLP-1 RAs in Type 2 Diabetes: ENDOCARE, a Pragmatic Prospective Cohort Study." Cardiovascular Diabetology, vol. 25, no. 1, 2026, https://doi.org/10.1186/s12933-026-03156-6.